Index | S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care |
Investment focus | Equity, World, Health Care, Social/Environmental |
Fund size | GBP 201 m |
Total expense ratio | 0.18% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | Yes |
Fund currency | EUR |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | 10.60% |
Inception/ Listing Date | 20 September 2022 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | Amundi ETF |
Fund Structure | Company With Variable Capital (SICAV) |
UCITS compliance | Yes |
Administrator | HSBC Securities Services (Ireland) DAC |
Investment Advisor | |
Custodian Bank | HSBC BANK PLC |
Revision Company | - |
Fiscal Year End | 31 December |
Swiss representative | NO |
Swiss paying agent | NO |
Germany | 30% tax rebate |
Switzerland | No ESTV Reporting |
Austria | Non-Tax Reporting Fund |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | |
Securities lending | No |
Securities lending counterparty |
Eli Lilly & Co. | 9.24% |
UnitedHealth Group | 8.47% |
Novo Nordisk A/S | 6.19% |
AbbVie, Inc. | 5.90% |
AstraZeneca PLC | 5.36% |
Merck & Co., Inc. | 4.09% |
Roche Holding AG | 3.93% |
Novartis AG | 3.61% |
Abbott Laboratories | 3.48% |
Elevance Health, Inc. | 2.63% |
United States | 65.70% |
Switzerland | 8.89% |
United Kingdom | 5.57% |
Japan | 4.81% |
Other | 15.03% |
Health Care | 92.60% |
Consumer Discretionary | 0.60% |
Other | 6.80% |
YTD | +8.69% |
1 month | +0.10% |
3 months | +4.88% |
6 months | +5.78% |
1 year | +18.89% |
3 years | - |
5 years | - |
Since inception (MAX) | +13.04% |
2023 | +0.11% |
2022 | - |
2021 | - |
2020 | - |
Volatility 1 year | 10.60% |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | 1.78 |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | -5.70% |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -11.61% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | WELS | - - | - - | - |
SIX Swiss Exchange | USD | WEL9 | WEL9 SW IWEL9 | WEL9.S IWEL9USDINAV=SOLA | BNP Paribas Arbitrage |
XETRA | USD | WEL9 | WEL9 GY IWEL9 | WELSGUSD.DE IWEL9USDINAV=SOLA | BNP Paribas Arbitrage |
XETRA | EUR | WELS | WELS GY IWELS | WELSG.DE IWELSEURINAV=SOLA | BNP Paribas Arbitrage |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Healthcare Innovation UCITS ETF | 1,022 | 0.40% p.a. | Accumulating | Sampling |
iShares Ageing Population UCITS ETF | 431 | 0.40% p.a. | Accumulating | Sampling |
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C | 123 | 0.35% p.a. | Accumulating | Full replication |
iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc) | 107 | 0.18% p.a. | Accumulating | Sampling |
VanEck Genomics and Healthcare Innovators UCITS ETF A | 7 | 0.35% p.a. | Accumulating | Full replication |